Share This

Related Topics News -

     
 Detail   |   Print    Next page > 
     
《盈喜》李氏大藥廠預計純利大升 全年最少賺8,300萬元
2025-03-19T  
174個藥品中選全國中成藥集採 料4月落地執行
2025-02-12T  
李氏大藥廠廣州土地被收回 獲補償8,920萬人民幣
2024-12-31T  
《大行》瑞銀:第十輪集採藥品降價幅度超預期 對中國仿製藥市場態度審慎
2024-12-19T  
李家超:長遠目標設立香港藥監局 可與內地共同發揮臨床試驗優勢
2024-12-11T  
衛生署:「1+」審批機制11月起擴展至所有新藥 體現「好藥港用」
2024-10-25T  
《施政報告》加快改革藥械審批制度 體現「好藥港用」
2024-10-16T  
李氏大藥廠重組安菲博肽注射液臨床試驗申請獲受理
2024-10-15T  
盧寵茂:「1+」機制累計接獲逾250個查詢 已批准5款新藥申請
2024-09-27T  
《業績》李氏大藥廠半年純利6,247.8萬元升287.7% 派中期息2仙
2024-08-28T  
  Next page > 

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2025 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.